drugset / Trial / NCT02966951
Use of Adipose Tissue Derived Mesenchymal Stem Cells for Knee Osteoarthrosis
NaSingle-groupOpen-labelTreatment
Summary
Adipose tissue derived Mesenchymal Stem cells (ATMSC) will be injected in patients diagnosed with Knee osteoarthrosis
Timeline
- Start
- 2017-01-17
- Primary completion
- 2021-09
- Completion
- 2021-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adipose tissue derived mesenchymal stem cell | Cell therapy | 5e+07 cells | Other |